Appropriate use criteria

Last updated

Appropriate use criteria (AUC), sometimes referred to as appropriateness criteria (AC), specify when it is appropriate to perform a medical procedure or service. An "appropriate" procedure is one for which the expected health benefits exceed the expected health risks by a wide margin. Ideally, AUC are evidence-based, but in the absence of sufficient evidence, may be derived from a consensus of expert opinion. AUC are typically classified in terms of the quality of the evidence on which they are based. In general, AUC are promulgated by medical specialty organizations (professional societies).[ citation needed ] The definition of "appropriate" is subject to interpretation. For example, a key issue is whether or not a procedure or investigation can be deemed appropriate if it does not result in a change in management. [1]

Relative costs of alternative appropriate procedures may or may not be considered in selecting a procedure for an individual patient, but in there is evidence that performing only appropriate procedures reduces volume [2] and cost. [3] To reduce the cost of (advanced) diagnostic imaging tests, a requirement for the use of clinical decision support for was included in the Protecting Access to Medicare Act of 2014, though it does not apply to emergency or inpatient services.

AUC are not always consistent between sources, or with other guidelines, or with reimbursement decisions. [4] [5] Additionally, AUC have not shown an impact in physician's behaviour. [6] AUC may be promulgated in human-readable form, or converted into an electronic structured form for use in a clinical decision support system, such as a computerized physician order entry system.

Related Research Articles

Echocardiography sonogram of the heart

An echocardiography, echocardiogram, cardiac echo or simply an echo, is an ultrasound of the heart.

Infective endocarditis endocarditis that is characterized by inflammation of the endocardium caused by infectious agents.

Infective endocarditis is an infection of the inner surface of the heart, usually the valves. Symptoms may include fever, small areas of bleeding into the skin, heart murmur, feeling tired, and low red blood cell count. Complications may include backward blood flow in the heart, the heart struggling to pump a sufficient amount of blood to meet the body's needs, abnormal electrical conduction in the heart, stroke, and kidney failure.

Aortic insufficiency aortic valve disease that is characterized by leaking of the aortic valve of the heart causes blood to flow in the reverse direction during ventricular diastole, from the aorta into the left ventricle

Aortic insufficiency (AI), also known as aortic regurgitation (AR), is the leaking of the aortic valve of the heart that causes blood to flow in the reverse direction during ventricular diastole, from the aorta into the left ventricle. As a consequence, the cardiac muscle is forced to work harder than normal.

Cardiac stress test Measures the hearts ability to respond to external stress in a controlled clinical environment

A cardiac stress test is a cardiological test that measures the heart's ability to respond to external stress in a controlled clinical environment. The stress response is induced by exercise or by intravenous pharmacological stimulation.

Transesophageal echocardiogram type of echocardiogram

A transesophageal echocardiogram, or TEE, is an alternative way to perform an echocardiogram. A specialized probe containing an ultrasound transducer at its tip is passed into the patient's esophagus. This allows image and Doppler evaluation which can be recorded.

Left ventricular hypertrophy

Left ventricular hypertrophy (LVH) is thickening of the heart muscle of the left ventricle of the heart, that is, left-sided ventricular hypertrophy.

Cardiac markers are biomarkers measured to evaluate heart function. They can be useful in the early prediction or diagnosis of disease. Although they are often discussed in the context of myocardial infarction, other conditions can lead to an elevation in cardiac marker level.

Tachycardia-induced cardiomyopathy (TIC) is a disease where prolonged tachycardia or arrhythmia causes an impairment of the myocardium, which can result in heart failure. People with TIC may have symptoms associated with heart failure and/or symptoms related to the tachycardia or arrhythmia. Though atrial fibrillation is the most common cause of TIC, several tachycardias and arrhythmias have been associated with the disease.

Percutaneous coronary intervention medical techniques used to manage coronary occlusion

Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing of the coronary arteries of the heart found in coronary artery disease. The process involves combining coronary angioplasty with stenting, which is the insertion of a permanent wire-meshed tube that is either drug eluting (DES) or composed of bare metal (BMS). The stent delivery balloon from the angioplasty catheter is inflated with media to force contact between the struts of the stent and the vessel wall, thus widening the blood vessel diameter. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualise the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open. Various other procedures can also be performed.

Disopyramide chemical compound

Disopyramide is an antiarrhythmic medication used in the treatment of ventricular tachycardia. It is a sodium channel blocker and therefore classified as a Class 1a anti-arrhythmic agent. Disopyramide has a negative inotropic effect on the ventricular myocardium, significantly decreasing the contractility. Disopyramide also has an anticholinergic effect on the heart which accounts for many adverse side effects. Disopyramide is available in both oral and intravenous forms, and has a low degree of toxicity.

Avijit Lahiri is a researcher in cardiology in the UK.

The Canadian Cardiovascular Society (CCS) is the national voice for cardiovascular physicians and scientists in Canada. The CCS is a membership organization that represents more than 1,800 professionals in the cardiovascular field. Its mission is to promote cardiovascular health and care through knowledge translation, professional development and leadership in health policy.

Intima-media thickness measurement of the thickness of artery walls

Intima–media thickness (IMT), also called intimal medial thickness, is a measurement of the thickness of tunica intima and tunica media, the innermost two layers of the wall of an artery. The measurement is usually made by external ultrasound and occasionally by internal, invasive ultrasound catheters. Measurements of the total wall thickness of blood vessels can also be done using other imaging modalities.

Jonathan L. Halperin is an American cardiologist and the author of Bypass (ISBN 0-89586-509-2), among the most comprehensive works on the subject of coronary artery bypass surgery. In addition, he is the Robert and Harriet Heilbrunn Professor of Medicine at The Mount Sinai School of Medicine as well as Director of Clinical Cardiology in the Zena and Michael A. Wierner Cardiovascular Institute at The Mount Sinai Medical Center, both in New York City. Halperin was the principal cardiologist responsible for both the design and execution of the multi-center Stroke Prevention in Atrial Fibrillation (SPAF) clinical trials, funded by the National Institutes of Health, which helped develop antithrombotic strategies to prevent stroke, and he subsequently directed the SPORTIF clinical trials, which evaluated the first oral direct thrombin inhibitor for prevention of stroke in patients with atrial fibrillation.

A diagnosis of myocardial infarction is created by integrating the history of the presenting illness and physical examination with electrocardiogram findings and cardiac markers. A coronary angiogram allows visualization of narrowings or obstructions on the heart vessels, and therapeutic measures can follow immediately. At autopsy, a pathologist can diagnose a myocardial infarction based on anatomopathological findings.

Impella is a family of medical devices used for temporary ventricular support in patients with depressed heart function. Some versions of the device can provide right heart support during other forms of mechanical circulatory support including ECMO and Centrimag.

Cardiac imaging visualization of the heart structure and cardiac blood flow for diagnostic evaluation or to guide cardiac procedures

Cardiac imaging refers to non-invasive imaging of the heart using ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), or nuclear medicine (NM) imaging with PET or SPECT. These cardiac techniques are otherwise referred to as echocardiography, Cardiac MRI, Cardiac CT, Cardiac PET and Cardiac SPECT including myocardial perfusion imaging.

John S. Rumsfeld is Chief Innovation Officer for the American College of Cardiology, and Professor of Medicine at the University of Colorado School of Medicine. He was previously the National Director of Cardiology for the U.S. Veterans Health Administration. Rumsfeld was named as Chief Innovation Officer for American College of Cardiology in 2015.

Overscreening, also called unnecessary screening, is the performance of medical screening without a medical indication to do so. Screening is a medical test in a healthy person who is showing no symptoms of a disease and is intended to detect a disease so that a person may prepare to respond to it. Screening is indicated in people who have some threshold risk for getting a disease, but is not indicated in people who are unlikely to develop a disease. Overscreening is a type of unnecessary health care.

Numerical manipulation of Doppler parameters obtain during routine Echocardiography has been extensively utilized to non-invasively estimate intra-cardiac pressures, in many cases removing the need for invasive cardiac catheterization.

References

  1. ↑ Armstrong W; Eagle K. A. (23 September 2013). "Appropriate Use Criteria in Cchocardiography: Is No Change the Same as No Benefit?". JAMA Internal Medicine. 173 (17): 1609–1610. doi:10.1001/jamainternmed.2013.7273. ISSN   2168-6106. PMID   23877483.
  2. ↑ Blackmore, C. Craig; Robert S. Mecklenburg; Gary S. Kaplan (January 2011). "Effectiveness of Clinical Decision Support in Controlling Inappropriate Imaging". Journal of the American College of Radiology. 8 (1): 19–25. doi:10.1016/j.jacr.2010.07.009. PMID   21211760.
  3. ↑ Puri, Pranav; Bobette Patterson; Jennifer Carrol; Darshan Hullon; Sanjeev Puri (12 March 2013). "The Economic Impact of Implementation of Appropriate Use Criteria on Volume of PCI Cases and Medical Cost Savings at a Large Community Hospital". Journal of the American College of Cardiology. 61 (10_S): E1499. doi: 10.1016/S0735-1097(13)61499-0 . ISSN   0735-1097.
  4. ↑ Fonseca, R.; Negishi, K.; Marwick, T. H. (1 August 2015). "What Is the Evidence Status of Appropriate Use Criteria (AUC)? Insight from a Matching Exercise with the Guidelines for Echocardiography". Internal Medicine Journal. 45 (8): 864–869. doi:10.1111/imj.12829. ISSN   1445-5994. PMID   26220028.
  5. ↑ Fogel, Richard I.; Andrew E. Epstein; N. A. Mark Estes III; Bruce D. Lindsay; John P. DiMarco; Mark S. Kremers; Suraj Kapa; Ralph G. Brindis; Andrea M. Russo (7 January 2014). "The Disconnect Between the Guidelines, the Appropriate Use Criteria, and Reimbursement Coverage Decisions: The Ultimate Dilemma". Journal of the American College of Cardiology. 63 (1): 12–14. doi: 10.1016/j.jacc.2013.07.016 . ISSN   0735-1097. PMID   23916934.
  6. ↑ Fonseca, R.; Negishi, K.; Otahal, P.; Marwick, T. H. (2015). "Temporal Changes in Appropriateness of Cardiac Imaging". Journal of the American College of Cardiology. 65 (8): 763–73. doi: 10.1016/j.jacc.2014.11.057 . ISSN   0735-1097. PMID   25720619.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.